Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 807-715-4 | CAS number: 1354569-12-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Effects on fertility
Description of key information
In accordance with REACH Article 18, testing is not required for this type of submission.
Classification and labelling are based on negative i) in vitro screening bioassays in human embryonic stem cells (Klimisch 2) and ii) a TOPKAT QSAR modelling .
Effect on fertility: via oral route
- Endpoint conclusion:
- no study available
Effect on fertility: via inhalation route
- Endpoint conclusion:
- no study available
Effect on fertility: via dermal route
- Endpoint conclusion:
- no study available
Additional information
In accordance with REACH Article 18, testing is not required for this type of submission.
Short description of key information:
In accordance with REACH Article 18, testing is not required for this type of submission.
Effects on developmental toxicity
Description of key information
In accordance with REACH Article 18, testing is not required for this type of submission.
Effect on developmental toxicity: via oral route
- Endpoint conclusion:
- no study available
Effect on developmental toxicity: via inhalation route
- Endpoint conclusion:
- no study available
Effect on developmental toxicity: via dermal route
- Endpoint conclusion:
- no study available
Additional information
In accordance with REACH Article 18, testing is not required for this type of submission.
Toxicity to reproduction: other studies
Additional information
An in vitro human embryonic stem based devTOX Discovery assay and associated statistical models (metabolomics) were applied for predicting the potential for developmental toxicity. Exposure to bis(2-ethylhexyl) citraconate was made for three treatment levels (3, 30, and 300 μM). Based on these data, the compound did not show metabolic perturbation indicative of the potential to exhibit teratogenicity over the exposure range studied. In addition, the compound showed no cytotoxcity over the exposure range tested in either the dose ranging or metabolomics portions of the study. Only two significantly changed mass features were detected when treated cells were compared with DMSO controls, further indicating the compound exerts little impact on the growth and metabolism of hES cells. The study was conducted in accordance with Stemina's Standard Operating Procedures under non-GLP (non applicable OECD or EU test methods were yet available). The results are rated as Klimisch 2 and used as weight of evidence for classification and labelling and PBT assessment.
The extended TOPKAT QSAR model predicts the developmental toxicity potential of the test substance as negative with moderate confidence. An external expert assessment verifies that the 5 OECD principles for QSAR models validation are met. The prediction is therefore considered as Klimisch 2 and used as weight of evidence for classification and labelling and PBT assessment.
Conclusion:
Based on negative weight of evidence from in vitro screening assays on human embryonic cells and TOPKAT modelling results, there are no indications of reproductive toxicity of bis(2 -ethylhexyl)citraconate to humans.
Justification for classification or non-classification
In accordance with REACH Article 18, testing is not required for this type of submission.
Non-classification and labelling are based on negative weight of evidence from in vitro metabolomics study on human embryonic stem cells and TOPKAT QSAR modelling.
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.